Syndax Pharmaceuticals Inc (SNDX) › RevenueSyndax Pharmaceuticals Inc (SNDX) — RevenueAnnual figures by fiscal year, from SEC filings.2016: $1.22M2017: $2.11M2018: $1.52M2019: $1.52M2020: $1.52M2021: $139.71M2022: $02023: $02024: $23.68M2025: $172.35M$172.35M2016Revenue (USD)2025Fiscal YearRevenueChange YoY2025$172.35M+627.8%2024$23.68M—2023$0—2022$0-100.0%2021$139.71M+9109.6%2020$1.52M+0.0%2019$1.52M+0.0%2018$1.52M-28.0%2017$2.11M+72.8%2016$1.22M—Other metrics: Cost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share